September 7, 2016 / 3:24 PM / a year ago

BRIEF-Aralez acquires U.S., Canadian rights to Zontivity from Merck

Sept 7 (Reuters) - Aralez Pharmaceuticals Inc

* Aralez acquires united states and canadian rights to Zontivity from Merck

* Says Merck will continue to distribute product on behalf of Aralez

* Says asset purchase agreement entered into between Merck, and Aralez Pharmaceuticals Trading DAC, unit of Aralez

* Says asset purchase agreement included an initial upfront payment of $25 million, which was paid from cash on hand

* Product rights, packaging, labeling and other responsibilities transferred to Aralez Pharmaceuticals Trading DAC Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below